Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pseudomonas syringae pv. syringae (Pss) is a Gram-negative, aerobic bacterium that serves as a significant plant pathogen with an exceptionally broad host range, including woody and herbaceous plants (Young, 1991). It is distinguished from other pathovars by its production of the lipodepsipeptide toxins syringomycin and syringopeptin, which form pores in host plasma membranes to induce nutrient leakage and cell death (Hutchison and Gross, 1997). A key feature of Pss is its ice nucleation activity, mediated by specialized surface proteins that catalyze ice crystal formation at temperatures just below freezing, thereby causing frost injury that facilitates bacterial entry (Lindow, 1983). In agricultural settings, Pss is the causative agent of diseases such as bacterial canker of stone fruits and bacterial brown spot of beans (Kennelly et al., 2007). Control measures typically involve the application of copper-based bactericides or antibiotics like streptomycin, although the emergence of resistant strains poses a significant challenge to disease management (Sundin, 2002). Because Pss is a whole organism rather than a specific protein or receptor, it is classified as a biological target for antimicrobial therapy rather than a molecular target.
Inhibition of the 30S ribosomal subunit to prevent protein synthesis (streptomycin); induction of oxidative stress and non-specific protein denaturation (copper ions) (Sundin, 2002).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudomonas syringae pv. syringae (Pss) (Pss).